Stockscreener 앱 받기
1.21%
전일 마감가:
$118.00
열려 있는:
$117.25
하루 거래량:
1.74M
Relative Volume:
0.23
시가총액:
$142.09B
수익:
$14.88B
순이익/손실:
$6.10B
주가수익비율:
29.85
EPS:
3.8977
순현금흐름:
$869.79M
1주 성능:
-1.68%
1개월 성능:
-4.07%
6개월 성능:
-20.38%
1년 성능:
-15.78%
1일 변동 폭
$114.50
$117.87
1주일 범위
$114.50
$120.33
52주 변동 폭
$101.73
$190.09
블랙스톤 Stock (BX) Company Profile
명칭
Blackstone Inc
전화
(212) 583-5000
주소
345 PARK AVENUE, NEW YORK, NY
Compare BX vs BLK, BN, KKR, BAM
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
BX
Blackstone Inc
|
116.33 | 144.14B | 14.88B | 6.10B | 869.79M | 3.8977 |
BLK
Blackrock Inc
|
1,049.75 | 166.15B | 26.28B | 6.75B | 3.76B | 38.77 |
BN
Brookfield Corp
|
46.21 | 102.77B | 77.61B | 4.06B | -8.36B | 0.497 |
KKR
Kkr Co Inc
|
93.65 | 85.32B | 22.38B | 5.74B | 8.54B | 2.9339 |
BAM
Brookfield Asset Management Ltd
|
49.05 | 78.23B | 5.07B | 2.48B | 2.37B | 1.5532 |
블랙스톤 Stock (BX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-04-13 | 업그레이드 | Oppenheimer | Perform → Outperform |
| 2026-03-05 | 재개 | Barclays | Equal Weight |
| 2026-02-24 | 개시 | RBC Capital Mkts | Outperform |
| 2025-12-11 | 재개 | UBS | Neutral |
| 2025-10-03 | 개시 | BMO Capital Markets | Outperform |
| 2025-04-08 | 업그레이드 | Citizens JMP | Mkt Perform → Mkt Outperform |
| 2025-03-17 | 업그레이드 | UBS | Neutral → Buy |
| 2024-12-12 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2024-12-09 | 업그레이드 | TD Cowen | Hold → Buy |
| 2024-10-09 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2024-09-12 | 개시 | Wells Fargo | Overweight |
| 2024-08-27 | 개시 | Redburn Atlantic | Neutral |
| 2024-04-02 | 다운그레이드 | UBS | Buy → Neutral |
| 2024-01-19 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2024-01-11 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2024-01-04 | 개시 | TD Cowen | Market Perform |
| 2024-01-03 | 다운그레이드 | Goldman | Buy → Neutral |
| 2023-12-20 | 재개 | Piper Sandler | Overweight |
| 2023-12-06 | 재개 | BMO Capital Markets | Market Perform |
| 2023-10-06 | 개시 | HSBC Securities | Hold |
| 2023-10-05 | 개시 | Wolfe Research | Peer Perform |
| 2023-07-21 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2023-05-19 | 개시 | Citigroup | Buy |
| 2023-04-13 | 업그레이드 | Oppenheimer | Perform → Outperform |
| 2023-01-24 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2023-01-11 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2022-12-02 | 다운그레이드 | Barclays | Overweight → Equal Weight |
| 2022-11-22 | 다운그레이드 | Credit Suisse | Neutral → Underperform |
| 2022-10-19 | 개시 | Credit Suisse | Neutral |
| 2022-10-11 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2022-08-31 | 개시 | Barclays | Overweight |
| 2022-07-25 | 다운그레이드 | Keefe Bruyette | Outperform → Mkt Perform |
| 2022-04-07 | 다운그레이드 | Exane BNP Paribas | Outperform → Neutral |
| 2021-12-16 | 재개 | BofA Securities | Buy |
| 2021-12-16 | 개시 | Wells Fargo | Equal Weight |
| 2021-11-04 | 재개 | BofA Securities | Buy |
| 2021-08-11 | 업그레이드 | Deutsche Bank | Hold → Buy |
| 2021-03-19 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2021-01-14 | 개시 | Piper Sandler | Overweight |
| 2020-10-29 | 업그레이드 | Oppenheimer | Perform → Outperform |
| 2020-06-25 | 개시 | UBS | Buy |
| 2020-06-08 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2019-10-14 | 다운그레이드 | BofA/Merrill | Buy → Neutral |
| 2019-10-08 | 개시 | BMO Capital Markets | Market Perform |
| 2019-10-01 | 개시 | Wells Fargo | Outperform |
| 2019-09-24 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2019-09-23 | 재확인 | BofA/Merrill | Buy |
| 2019-09-18 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2019-08-05 | 개시 | Barclays | Overweight |
| 2019-07-08 | 다운그레이드 | JMP Securities | Mkt Outperform → Mkt Perform |
| 2018-01-12 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2017-05-22 | 업그레이드 | Citigroup | Neutral → Buy |
| 2016-03-11 | 다운그레이드 | Deutsche Bank | Buy → Hold |
| 2016-02-02 | 재확인 | Argus | Buy |
| 2016-01-26 | 재확인 | RBC Capital Mkts | Outperform |
| 2016-01-08 | 재확인 | Deutsche Bank | Buy |
| 2015-12-08 | 다운그레이드 | BofA/Merrill | Buy → Neutral |
| 2015-11-23 | 개시 | JP Morgan | Neutral |
| 2015-10-27 | 재확인 | Argus | Buy |
모두보기
블랙스톤 주식(BX)의 최신 뉴스
Blackstone bets up to 1.3 billion on Apogee Therapeutics - Il Sole 24 ORE
Foundations Investment Advisors LLC Buys 21,913 Shares of Blackstone Inc. $BX - MarketBeat
Geode Capital Management LLC Decreases Stock Position in Blackstone Inc. $BX - MarketBeat
Key facts: Blackstone to fund Apogee $1.3B; backs Ksi Lisims - TradingView
Apogee Therapeutics Soars After $1.3B Deal with Blackstone Life Sciences - StockInvest.us
Inside Blackstone: Stephen A. Schwarzman on long-term investing across cycles - Livewire Markets
Blackstone closes in on HSBC’s $26bn mortgage book - The Australian
Apogee’s Royalty Deal With Blackstone Will Fund Pivotal Test in Eczema and More - MedCity News
Apogee Doubles Its Cash Position As It Reports New Phase II Zumilokibart Data - Citeline News & Insights
Young biotech Apogee lands $1.3B deal that is called 'largest royalty financing' of its kind - The Business Journals
Apogee secures up to $1.3 billion from Blackstone to advance eczema drug - Reuters
Blackstone Products is recalling its Parmesan Ranch seasoning sold at Walmart over salmonella fears - qz.com
Ranch products recalled from NC Walmarts in ongoing salmonella issue - The Asheville Citizen Times
Blackstone Backs Apogee With Up To $1.3 Billion - TradingView
Waltham Biotech Company Gets Big Financial Boost To Develop Eczema Drug: Report - Patch
Blackstone Inc. stock: Why its latest portfolio moves matter - AD HOC NEWS
Recall alert: Blackstone seasoning sold at Walmart recalled for possible Salmonella - WSB-TV
12 Most Profitable Stocks to Invest In - Insider Monkey
FDA Recalls Walmart Blackstone Parmesan Ranch Nationwide Warning Over Possible Salmonella Contamination - Nbsla.ca
Blackstone Life Sciences commits up to $1.3B to fund Waltham biotech's drug - The Business Journals
Apogee Therapeutics, Inc. announced that it expects to receive $500 million in funding - marketscreener.com
Ranch Seasoning Recalled for Potential Salmonella Contamination - People.com
New CLOs at Blackstone, Guggenheim Boast Key Perk: Less Software - Bloomberg
Apogee lands $800M royalty deal with Blackstone to move Dupixent rival toward Phase 3 - Endpoints News
Blackstone Parmesan Ranch Recalled in Canada For Salmonella - Food Poisoning Bulletin
Wellness Alert: What You Need to Know About the Blackstone Parmesan Ranch Seasoning Recall - SW Newsmagazine
News | Blackstone Mileway UK CMBS prepared in boost to flagging market - CoStar
Apogee Stock Slides After Blackstone Financing Deal And Positive Drug Data - Benzinga
Blackstone Injecting Up to $1.3 Billion in Apogee for Skin Drug - Bloomberg
Apogee Therapeutics IncBlackstone Life Sciences to pay $100 million upfront for revenue share on Zumilokibart salesSEC filing - marketscreener.com
Apogee Therapeutics secures $1.3 billion Blackstone financing deal, shares dive - Investing.com Nigeria
Apogee Therapeutics Secures Up to $1.3B From Blackstone to Fund Late-Stage Drug Push - citybiz
Apogee Therapeutics Shares Surge Following $1.3 Billion Blackstone Financing Partnership (APOG) - Yahoo Finance
William Blair Investment Management LLC Has $7.22 Million Stake in Blackstone Inc. $BX - MarketBeat
Apogee Therapeutics shares jump on $1.3B Blackstone deal By Investing.com - Investing.com Nigeria
Apogee secures up to $1.3 billion financing from Blackstone By Investing.com - Investing.com Australia
Apogee secures up to $1.3 billion financing from Blackstone - Investing.com
Apogee Therapeutics shares jump on $1.3B Blackstone deal - Investing.com
Apogee Therapeutics Announces $1.3 Billion Strategic Financing Collaboration with Blackstone Life Sciences to Advance Phase 3 Development and Commercialization of Zumilokibart - The Manila Times
Apogee Therapeutics (Nasdaq: APGE) secures up to $1.3B from Blackstone - Stock Titan
CPP Investments sells portfolio of 33 fund interests to Blackstone, Ardian - AltAssets Private Equity News
Blackstone backs up to $1.3B for Apogee atopic dermatitis therapy - Stock Titan
Blackstone injecting up to $1.3 billion in Apogee for skin drugBloomberg News - TradingView
Allstate Corp Has $8.50 Million Stock Holdings in Blackstone Inc. $BX - MarketBeat
Walmart Blackstone Parmesan Ranch Recall Sparks Investor Alarm After 4-Year Stock Slide - Freedom For All Americans
United StatesLowenstein Represents Fractional AI, A Leading Applied-AI Services Company, In Its Acquisition By JV Backed By Anthropic, Blackstone, And Hellman & Friedman - Mondaq
A Look At Blackstone (BX) Valuation After New Google Data Center Joint Venture Announcement - simplywall.st
Walmart issues nationwide recall for Blackstone parmesan ranch seasoning over fatal infection risk - New York Post
UBS (AMUB) offers autocallable notes linked to Blackstone with contingent coupon - Stock Titan
[Form 4] Medline Inc. Insider Trading Activity - Stock Titan
Landowners Urge Virginia Top Court To Pass On Blackstone's Digital Gateway Fight - Bisnow
블랙스톤 (BX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.51%
자본화:
|
볼륨(24시간):